載入...
Acquired and intrinsic resistance in cancer immunotherapy
A number of immunotherapies, in particular immune checkpoint targeting antibodies and adoptive T‐cell therapies, are starting to transform the treatment of advanced cancers. The likelihood to respond to these immunotherapies differs strongly across tumor types, with response rates for checkpoint tar...
Na minha lista:
發表在: | Mol Oncol |
---|---|
Main Authors: | , , |
格式: | Artigo |
語言: | Inglês |
出版: |
John Wiley and Sons Inc.
2014
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5528612/ https://ncbi.nlm.nih.gov/pubmed/25106088 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2014.07.011 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|